程序性死亡分子—1及其配体在非小细胞肺癌中的治疗进展(5)
[21] Chen N，Fang W，Zhan J，et al. Upregulation of PD-L1 by EGFR activation mediates the immune escape in EGFR-driven NSCLC：implication for optional immune targeted therapy for NSCLC patients with EGFR mutation [J]. J Thorac Oncol，2015，10(6)：910-923.[22] D’Incecco A，Andreozzi M，Ludovini V ......
您现在查看是摘要页，全文长 2620 字符。